Return to content in this issue

Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain

Barroso B^1*, Valverde-Monge M^1*, Cañas Jose A^2,5, Rodrigo- Muñoz JM^2,5, Gonzalez-Cano B¹, Villalobos-Violan V¹, Betancor D¹, Gomez-Cardeñosa A¹, Vallejo-Chamorro G¹, Baptista-Serna L¹, Villalobos-Vilda C¹, Ortega-Martin L¹, Gómez- López A¹, Sanchez-Pernaute O³, Romero-Bueno F³, Rodriguez- Nieto MJ⁴, Del Pozo V^2,5, Sastre J^1,5 and the COVID-FJD TEAM

¹Allergy Department, Hospital Universitario Fundación Jiménez Díaz and Instituto de Investigación sanitaria (IIS) Fundación Jiménez Díaz, Madrid, Spain
²Immunology Department, Hospital Universitario Fundación Jiménez Díaz and Instituto de Investigación sanitaria (IIS) Fundación Jiménez Díaz, Madrid, Spain
³Rheumatology Department, Hospital Universitario Fundación Jiménez Díaz and Instituto de Investigación sanitaria (IIS) Fundación Jiménez Díaz, Madrid, Spain
⁴Pulmunology Department, Hospital Universitario Fundación Jiménez Díaz and Instituto de Investigación sanitaria (IIS) Fundación Jiménez Díaz, Madrid, Spain
⁵CIBER de Enfermedades Respiratorias (CIBERES)
^*Both authors contributed equally as first authors.

J Investig Allergol Clin Immunol 2020; Vol 30(5) : 382-384
doi: 10.18176/jiaci.0627

• Abstract
• Supplemental Materials

Key words: Asthma, Prevalence, COVID-19, Atopic diseases, SARS-CoV-2, Asthma Characterization

	Title	Type	Size
	doi10.1876_jiaci.0627_material-suppl_1.pdf	pdf	360.31 Kb